Vikram Singh

TVS Ronin: TVS Motors' two-wheelers are making headlines at the India Mobility Global Expo 2025. Especially the iQube concept as well as the CNG-powered

The powertrain of the Brezza Powerplay Concept has not been revealed yet, but it is expected that the company will retain the naturally aspirated petrol

Introduction Mental disorders are prevalent among older adults, often leading to the use of multiple medications, many with anticholinergic properties. Polypharmacy, common in this population, is a major contributor to anticholinergic burden, which is linked to cognitive and physical decline. This study investigates the relationship between polypharmacy and anticholinergic burden across seven anticholinergic burden scales in elderly patients attending the psychiatric outpatient. Methods Study was conducted at a psychiatry outpatient clinic at All India Institute of Medical Sciences, Rishikesh, India, from December 2021 to March 2023. Elderly patients (aged ≥ 60 years) who were on at least one psychotropic medication and had a primary working diagnosis of psychiatric illness were included. All psychotropic medications, including antidepressants, antipsychotics, mood stabilizers, and hypnotics, were evaluated. Anticholinergic burden scales were calculated by the respective tools. Univariate analysis was adopted to determine the factors that may affect polypharmacy. Results Study included 1165 elderly patients aged ≥ 60 years. The prevalence of polypharmacy was 20.43% (n = 238). Clonazepam (n = 364, 17.28%), escitalopram (n = 197, 9.35%), metformin (n = 165, 7.83%), sertraline (n = 141, 6.69%), mirtazapine (n = 129, 6.12%), and lorazepam (n = 110, 5.22%) were among the most frequently prescribed anticholinergic drugs. Univariate analysis demonstrated that all anticholinergic risk assessment scales were closely correlated with polypharmacy, with the strongest association observed for the Anticholinergic Load Scale (ALS) (Odds Ratio = 4.3; p < 0.001). Polypharmacy was also positively associated with adverse drug reactions (Odds Ratio = 1.81; 95% Confidence Interval = 1.27–2.56). Conclusion The anticholinergic burden in this cohort of elderly psychiatry patients was high, with 95.1% (n = 1108) experiencing a significant burden. Adverse drug events and anticholinergic burden scales were positively associated with polypharmacy, with a stronger correlation between polypharmacy and ALS scores than with other anticholinergic burden scales in older adults.

Hero Xoom 125: Hero has recently launched the Xoom 125 in the Indian market. It was first showcased at the 2024 EICMA show in Milan, Italy and now it has been

Tata Avinya X: Tata Motors, the largest seller of electric cars in the Indian market, participated in the India Mobility Global Expo. The company put the Tata

Tata Avinya X: Tata Motors, the largest seller of electric cars in the Indian market, participated in the India Mobility Global Expo. The company put the Tata Avinya X concept on its main stage at the 2025 Auto Expo. This futuristic car has made a mark in the hearts of the people. Let's know what is special in Avinya X.

Maruti Fronx Turbo Edition: Maruti Suzuki has introduced a special Turbo Edition of its popular Fronx SUV at Auto Expo 2025. The new Maruti Fronx Turbo

Hyundai Inster Cross EV: Many companies are launching vehicles at the India Mobility Global Expo 2025. Hyundai India made a splash by launching the Creta

Toyota Hilux FCEV: All the brands of the country and the world have participated in Bharat Mobility Global Expo 2025. In this episode, Toyota's pavilion

Located in the holy city of Puri, Odisha, the Gundicha Temple is a significant and revered religious site in India, particularly for followers of the Hindu faith.